Trial does not change the conclusions of Cochrane review of long term hormone therapy for perimenopausal and postmenopausal women

BMJ (Online)

Volumn 345, Issue 7886, 2012, Pages

  Marjoribanks, Jane ^a   Farquhar, Cindy ^a   Roberts, Helen ^a   Lethaby, Anne ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLIMACTERIUM; CLINICAL PROTOCOL; HORMONE SUBSTITUTION; HUMAN; LETTER; OPEN STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION; SYSTEMATIC REVIEW;

FEMALE; HEART FAILURE; HORMONE REPLACEMENT THERAPY; HUMANS; MYOCARDIAL INFARCTION; NEOPLASMS;

EID: 84870724129     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e8141     Document Type: Letter

References (2)

1. Schierbeck LL, Rejnmark L, Tofteng CL, Stilgren L, Eiken P, Mosekilde L, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012;345:e6409. (9 October.)
2. Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2012;7:CD004143.